GLIMEPRIDE:
It is a hypogycaemic agent belonging to the second generation sulfonylureas .
It appears to lower blood glucose by stimulating insulin release from beta cells in the pancreatic islets possibly due to increased intracellular cAMP
Indication:
- Non insulin dependent diabetes.